FIELD: medicine, neurology. SUBSTANCE: invention relates to treatment of acute and chronic cerebral insufficiency and neurodegenerative diseases also. For this purpose retigabin is used that is activator of potassium channels. Invention ensures to enhance effectiveness of indicated diseases due to use of preparation eliciting expressed neuroprotective properties. EFFECT: enhanced effectiveness of treatment. 3 cl, 1 tbl
Authors
Dates
2003-03-27—Published
1996-10-15—Filed